- Home
- MPU vs UNCY Comparison
MPU vs UNCY Comparison
Compare MPU & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPU
- UNCY
- Stock Information
- Founded
- MPU 1989
- UNCY 2016
- Country
- MPU Singapore
- UNCY United States
- Employees
- MPU N/A
- UNCY N/A
- Industry
- MPU Transportation Services
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- MPU Consumer Discretionary
- UNCY Health Care
- Exchange
- MPU Nasdaq
- UNCY Nasdaq
- Market Cap
- MPU 88.9M
- UNCY 74.2M
- IPO Year
- MPU 1998
- UNCY 2021
- Fundamental
- Price
- MPU $1.48
- UNCY $4.04
- Analyst Decision
- MPU
- UNCY Strong Buy
- Analyst Count
- MPU 0
- UNCY 5
- Target Price
- MPU N/A
- UNCY $55.20
- AVG Volume (30 Days)
- MPU 1.0M
- UNCY 425.0K
- Earning Date
- MPU 11-11-2025
- UNCY 11-12-2025
- Dividend Yield
- MPU N/A
- UNCY N/A
- EPS Growth
- MPU N/A
- UNCY N/A
- EPS
- MPU N/A
- UNCY N/A
- Revenue
- MPU $35,228,600.00
- UNCY N/A
- Revenue This Year
- MPU N/A
- UNCY N/A
- Revenue Next Year
- MPU N/A
- UNCY $4,481.14
- P/E Ratio
- MPU N/A
- UNCY N/A
- Revenue Growth
- MPU 305.32
- UNCY N/A
- 52 Week Low
- MPU $0.49
- UNCY $3.40
- 52 Week High
- MPU $4.44
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- MPU 35.60
- UNCY 41.84
- Support Level
- MPU $1.45
- UNCY $3.80
- Resistance Level
- MPU $1.60
- UNCY $4.21
- Average True Range (ATR)
- MPU 0.25
- UNCY 0.20
- MACD
- MPU -0.04
- UNCY -0.01
- Stochastic Oscillator
- MPU 15.29
- UNCY 38.10
About MPU Mega Matrix Corp.
Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.